Background: Epidermolysis bullosa (EB) is a group of devastating diseases in which patients have skin inflammation with epithelial fragility and recurrent blistering. Children with EB have poor linear growth, which is only partially reversed by nutritional supplementation. Pro-inflammatory cytokines impair growth in children with inflammatory bowel disease by inhibiting signal transduction from growth hormone (GH) to insulin-like growth factor-1 (IGF-1). We hypothesised that a similar mechanism occurred in EB.
